El informe
Noticias verificadas sobre financiación, sedes y liderazgo de las empresas más innovadoras del mundo
7 informes y contando
Ginkgo Bioworks Raises $350M in Series E
Ginkgo Bioworks, a Biotech company based in 27 Drydock Avenue, Boston, MA 02210, has raised $350M in Series E at a $4.9B valuation led by Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors.
Ginkgo Bioworks raises $1.5B PIPE at $15B valuation
Ginkgo Bioworks raises $1.5B in PIPE at $15B valuation. Synthetic biology and organism engineering platform...
Ginkgo Bioworks raises $350M Series E at $4.9B valuation
Ginkgo Bioworks raises $350M in Series E at $4.9B valuation. Synthetic biology and organism engineering...
Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation
Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.
Ginkgo Bioworks Headquarters - Office Location & Address
Discover Ginkgo Bioworks's headquarters at 27 Drydock Ave, Boston, MA 02210. Synthetic biology company. Learn about the office facilities and work environment.
Umami Bioworks Headquarters - Office Location & Address
Discover Umami Bioworks's headquarters at 61 Science Park Rd, Singapore, 117525. Cell-cultured seafood production. Learn about the office facilities and work environment.
BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology
BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.
Mostrando 7 informes • Página 1 • Categoría: all
Mantente a la vanguardia del mercado
Recibe insights semanales en tu bandeja de entrada. Sin spam, solo inteligencia.